Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


India Price Regulator Urged To Cut New Price Approvals To 30 Days

This article was originally published in PharmAsia News

Executive Summary

India's National Pharmaceutical Pricing Authority is being pressured by other parts of the government to cut in half the clearance time for pricing changes, which now take 60 days. The Department of Chemicals and Petrochemicals requested reduction of the approval period to 30 days to satisfy industry complaints about the recent increase in prices of bulk drugs from China. Many Indian drug makers have been applying for permission to raise prices, including those who make bulk drugs. Some industry groups urge a 20 percent increase in the consumer drugs, bulks by 25 percent. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts